Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.

Who May Qualify: - Patients aged 40 years or older, - Previously included in the glaucoma departments of the participating institutions, - Indication for cataract surgery, diagnosed by clinical examination with visual acuity (VA) equal to or worse than 20/40, - Primary Open Angle Glaucoma (POAG), determined by the presence of typical visual field (VF) defects and/or by the aspect of the optic nerve observed at fundoscopy or retinography (increased vertical optical excavation with thinning of the neural rhyme, asymmetry of the cup/disc ratio greater than 0.2, localized loss ("notch") or defect in the retinal nerve fiber layer ("Hoyt")). - APIC classification with amplitude greater/equal to 2 and pigmentation less than 4 on gonioscopy. - Intraocular pressure (IOP) less than or equal to 25 mmHg before washout of hypotensive eye drops. - IOP between 22 and 30 mmHg after washout of hypotensive eye drops or with a history of IOP greater than or equal to 21 mmHg in more than one previous care described in the medical record. Who Should NOT Join This Trial: Patients who have any of the following situations: - Severe glaucoma, determined according to the Hoddap-Parrish-Anderson criteria; - Axial diameter greater than 26 mm or less than 21.00 mm; - Endothelial count less than 1500 cc; - Pachymetry less than 480 or greater than 600 microns; - Patients undergoing some type of intraocular surgery or laser procedure in the preoperative period and/or after these procedures in the postoperative period; - Those who present some important per-operative complication during the study. - With high risk of progression, the so-called rapid progressors, who are patients with high IOPs even with the use of many medications, regardless of the severity of the nerve injury. Always talk to your doctor about whether this trial is right for you.